These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1902133

  • 21. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 22. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
    Arai R, Kimura H, Nagatsu I, Maeda T.
    Brain Res; 1997 Jan 16; 745(1-2):352-6. PubMed ID: 9037433
    [Abstract] [Full Text] [Related]

  • 23. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R, Botting R, Coulson P, Spanswick G.
    Br J Pharmacol; 1984 May 16; 82(1):151-4. PubMed ID: 6428496
    [Abstract] [Full Text] [Related]

  • 24. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS.
    Biokhimiia; 1983 Sep 16; 48(9):1513-21. PubMed ID: 6414536
    [Abstract] [Full Text] [Related]

  • 25. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.
    Lakshmana MK, Rao BS, Dhingra NK, Ravikumar R, Govindaiah, Sudha S, Meti BL, Raju TR.
    Neurochem Res; 1998 Aug 16; 23(8):1031-7. PubMed ID: 9704592
    [Abstract] [Full Text] [Related]

  • 26. A new method for in vivo measurement of brain monoamine oxidase activity.
    Inoue O, Tominaga T, Yamasaki T, Kinemuchi H.
    Prog Neuropsychopharmacol Biol Psychiatry; 1984 Aug 16; 8(3):385-95. PubMed ID: 6435178
    [Abstract] [Full Text] [Related]

  • 27. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.
    Seymour CB, Mothersill C, Mooney R, Moriarty M, Tipton KF.
    Br J Cancer; 2003 Nov 17; 89(10):1979-86. PubMed ID: 14612913
    [Abstract] [Full Text] [Related]

  • 28. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.
    Fowler JS, Logan J, Volkow ND, Shumay E, McCall-Perez F, Jayne M, Wang GJ, Alexoff DL, Apelskog-Torres K, Hubbard B, Carter P, King P, Fahn S, Gilmor M, Telang F, Shea C, Xu Y, Muench L.
    Neuropsychopharmacology; 2015 Feb 17; 40(3):650-7. PubMed ID: 25249059
    [Abstract] [Full Text] [Related]

  • 29. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L, Bunag RD.
    J Pharmacol Exp Ther; 1989 Nov 17; 251(2):645-9. PubMed ID: 2509682
    [Abstract] [Full Text] [Related]

  • 30. Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats.
    Timár J, Knoll B, Gyarmati Z, Knoll J.
    Pol J Pharmacol Pharm; 1979 Nov 17; 31(4):251-60. PubMed ID: 523335
    [Abstract] [Full Text] [Related]

  • 31. Radioactive N,N-dimethylphenylethylamine: a selective radiotracer for in vivo measurement of monoamine oxidase-B activity in the brain.
    Inoue O, Tominaga T, Yamasaki T, Kinemuchi H.
    J Neurochem; 1985 Jan 17; 44(1):210-6. PubMed ID: 3917289
    [Abstract] [Full Text] [Related]

  • 32. Rat thyroid monoamine oxidase (MAO) is regulated by thyrotrophin: evidence that the main form of the enzyme (MAO-A) is not directly involved in iodide organification.
    Cabanillas AM, Masini-Repiso AM, Coleoni AH.
    J Endocrinol; 1991 Oct 17; 131(1):25-31. PubMed ID: 1660515
    [Abstract] [Full Text] [Related]

  • 33. Monoamine oxidase in bovine thyroid tissue.
    Masini-Repiso AM, Cabanillas AM, Andrada MC, Coleoni AH.
    Horm Metab Res; 1986 Nov 17; 18(11):750-3. PubMed ID: 3098663
    [Abstract] [Full Text] [Related]

  • 34. Monoamine oxidase (MAO) activity and its forms in normal and pathological human thyroid tissues.
    Cabanillas AM, Masini-Repiso AM, Coleoni AH.
    Clin Endocrinol (Oxf); 1989 Jun 17; 30(6):681-6. PubMed ID: 2556223
    [Abstract] [Full Text] [Related]

  • 35. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
    Geha RM, Rebrin I, Chen K, Shih JC.
    J Biol Chem; 2001 Mar 30; 276(13):9877-82. PubMed ID: 11134050
    [Abstract] [Full Text] [Related]

  • 36. Effect of orthotopic liver transplantation and chemical denervation of the liver on the activities of hepatic monoamine oxidase and catechol-O-methyltransferase.
    Wheatley AM, McCrodden JM, Stuart ET, Zhao D, Shaw SG, Tipton KF, Blumgart LH.
    Transplantation; 1993 Jul 30; 56(1):202-7. PubMed ID: 8333043
    [Abstract] [Full Text] [Related]

  • 37. Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.
    Mishra R, Gillespie DD, Youdim MB, Sulser F.
    Psychopharmacology (Berl); 1983 Jul 30; 81(3):220-3. PubMed ID: 6316394
    [Abstract] [Full Text] [Related]

  • 38. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
    Strolin Benedetti M, Cocchiara G, Colombo M, Dostert P.
    J Neural Transm Suppl; 1990 Jul 30; 32():351-6. PubMed ID: 2128509
    [Abstract] [Full Text] [Related]

  • 39. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP, Lamensdorf I, Armoni T.
    Neurobiology (Bp); 2000 Jul 30; 8(2):137-42. PubMed ID: 11061211
    [Abstract] [Full Text] [Related]

  • 40. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM, Du GH.
    Acta Pharmacol Sin; 2006 Jun 30; 27(6):760-6. PubMed ID: 16723097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.